The Circuit Court of Appeals for the District of Columbia decided Tuesday afternoon to allow federally funded human embryonic stem cell research to continue, while the federal government appeals a lower court injunction that barred the work.
Recent Posts
- Stem cell model replicates human amniotic sac development past two weeks
- Infant becomes world’s first patient to undergo personalized gene-editing treatment
- Biotech Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
- Embryonic macrophages found to control blood stem cell numbers in bone marrow
- Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
- The stem cell race for Parkinson’s disease: Recent studies show significant promise